Pricing Log in Create free account

ABVC BioPharma, Inc. (ABVC) vs Cel-Sci Corporation (CVM)

ABVC BioPharma, Inc. and Cel-Sci Corporation are both Biotechnology companies. ABVC BioPharma, Inc. and Cel-Sci Corporation are of similar size ($25.9M and $24.1M). ABVC BioPharma, Inc. grew revenue faster over the last twelve months: 5,035.4% against 20.8%. Across the 15 metrics below, ABVC BioPharma, Inc. leads on 11 and Cel-Sci Corporation on 4.

Valuation

Metric ABVC CVM Biotechnology median
P/E n/m n/m 10.60
P/S 19.38 31.44 9.40
P/B 2.06 1.60 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 20.64 27.64 9.02
Earnings yield (35.01%) (184.94%) (32.88%)
Free cash flow yield (10.75%) (95.61%) (23.13%)

Profitability

Metric ABVC CVM Biotechnology median
Gross margin 99.97% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.32%) (252.53%) (51.96%)
Return on assets (39.88%) (108.91%) (46.06%)
Return on invested capital (33.45%) (169.59%) 0.00%

Growth

Metric ABVC CVM Biotechnology median
Revenue growth (TTM) 5,035.43% 20.75% 6.76%
EPS growth (last fiscal year) 7.14% 59.06% 29.88%
Revenue growth, 5-year CAGR (6.20%) 16.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVC CVM Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 0.07 1.48 4.97
Net debt to EBITDA 0.21 0.25 1.01

Dividend

Metric ABVC CVM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABVC CVM Biotechnology median
Market cap 25.92m 24.09m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack